A novel mechanism driving poor-prognostic gastric cancer: overexpression of the transcription factor Kruppel-like factor 16 promotes growth and metastasis of gastric cancer through regulating the Notch pathway

CNU IR > Pharmacy and Science > Dept. of Food Science & Technology > Periodical Articles > Item 310902800/34521

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34521

Title:	A novel mechanism driving poor-prognostic gastric cancer: overexpression of the transcription factor Kruppel-like factor 16 promotes growth and metastasis of gastric cancer through regulating the Notch pathway
Authors:	Sun, Ding-Ping Tian, Yu-Feng Lin, Chih-Chan Hung, Shih-Ting Uen, Yih-Huei Hseu, You-Cheng Chou, Chia-Lin Cheng, Li-Chin Wang, Wen-Ching Kuang, Yi-Yu Fang, Chia-Lang Lin, Kai-Yuan
Contributors:	Chi Mei Med Ctr, Dept Surg Chia Nan Univ Pharm & Sci, Dept Food Sci & Technol Chi Mei Med Ctr, Dept Med Res Asia Univ Hosp, Dept Surg Asia Univ, Dept Biotechnol Tainan Municipal Nan Hosp, Dept Surg China Med Univ, Dept Cosmeceut Asia Univ, Dept Hlth & Nutr Biotechnol China Med Univ, Chinese Med Res Ctr Taipei Med Univ, Sch Med, Coll Med, Dept Pathol Taipei Med Univ Hosp, Taipei Med Univ, Dept Pathol Chia Nan Univ Pharm & Sci, Dept Biotechnol
Keywords:	Gastric cancer KLF16 prognosis MFAP5 Notch pathway
Date:	2021
Issue Date:	2023-11-11 12:00:45 (UTC+8)
Publisher:	E-CENTURY PUBLISHING CORP
Abstract:	Gastric cancer (GC) is one of the most common malignant tumors worldwide and has high rates of morbidity and mortality. This study investigated the role of Kruppel-like factor 16 (KLF16) in GC. Real-time polymerase chain reaction, Western blotting, and immunohistochemistry were used to examine the expression of KLF16 in gastric cells and tissues. Gene overexpression and silencing were applied to study the involvement of KLF16 in GC cell growth and metastasis along with its underlying mechanism. The results indicate that KLF16 overexpression is significantly associated with nodal status, distant metastasis, staging, degree of differentiation, vascular invasion, and patient survival. Multivariate Cox proportional hazards regression model analysis revealed that the overexpression of KLF16 is an independent prognostic biomarker of GC. The in vitro study revealed that up-regulated KLF16 accelerates cell growth and metastasis, whereas the inhibition of KLF16 suppresses these cellular activities. The results of an animal study also indicated that the overexpression and silencing of KLF16 accelerate and repress xenograft proliferation and metastasis. Further studies of affected cell growth and metastasis revealed that KLF16 modulates the cell cycle and epithelial-mesenchymal transition through transcriptional regulation of microfibrillar-associated protein 5. Collectively, these results reveal that KLF16 overexpression is a potential prognostic biomarker and therapeutic target for the treatment of GC.
Relation:	AM J CANCER RES, v.11, n.6, pp.2717-2735
Appears in Collections:	[Dept. of Food Science & Technology] Periodical Articles [Dept. of Biotechnology (including master's program)] Periodical Articles

Files in This Item:

File	Description	Size	Format
ajcr0011-2717.pdf		3671Kb	Adobe PDF	89	View/Open
index.html		0Kb	HTML	291	View/Open

Loading...